|
1
|
Weetman AP: Graves' disease. N Engl J Med.
343:1236–1248. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jacobson DL, Gange SJ, Rose NR and Graham
NM: Epidemiology and estimated population burden of selected
autoimmune diseases in the United States. Clin Immunol
Immunopathol. 84:223–243. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Falgarone G, Heshmati HM, Cohen R and
Reach G: Mechanisms in endocrinology. Role of emotional stress in
the pathophysiology of Graves' disease. Eur J Endocrinol.
168:R13–R18. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chaar BT, Kudva GC, Olsen TJ, Silverberg
AB and Grossman BJ: Thrombotic thrombocytopenic purpura and Graves
disease. Am J Med Sci. 334:133–135. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Aydin Y, Berker D, Ustün I, Balcik O,
Balli DN, Delibasi T, Peksoy I and Guler S: A very rare cause of
aplastic anemia: Graves disease. South Med J. 101:666–667. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Soultati AS, Dourakis SP, Asvesti K, Nezi
V, Alexopoulou A and Archimandritis AJ: Autoimmune blistering
disease in a patient with Graves disease and vitiligo. Am J Med
Sci. 333:309–312. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Brix TH, Christensen K, Holm NV, Harvald B
and Hegedüs L: A population-based study of Graves' disease in
Danish twins. Clin Endocrinol (Oxf). 48:397–400. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tomer Y, Barbesino G, Greenberg DA,
Concepcion E and Davies TF: Mapping the major susceptibility loci
for familial Graves' and Hashimoto's diseases: Evidence for genetic
heterogeneity and gene interactions. J Clin Endocrinol Metab.
84:4656–4664. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Brix TH, Kyvik KO, Christensen K and
Hegedüs L: Evidence for a major role of heredity in Graves'
disease: A population-based study of two Danish twin cohorts. J
Clin Endocrinol Metab. 86:930–934. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ban Y, Davies TF, Greenberg DA, et al:
Analysis of the CTLA-4, CD28, and inducible costimulator (ICOS)
genes in autoimmune thyroid disease. Genes Immun. 4:586–593. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Brand OJ, Barrett JC, Simmonds MJ, et al:
Association of the thyroid stimulating hormone receptor gene (TSHR)
with Graves' disease. Hum Mol Genet. 18:1704–1713. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Heward JM, Allahabadia A, Armitage M, et
al: The development of Graves' disease and the CTLA-4 gene on
chromosome 2q33. J Clin Endocrinol Metab. 84:2398–2401. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jacobson EM, Huber A and Tomer Y: The HLA
gene complex in thyroid autoimmunity: From epidemiology to
etiology. J Autoimmun. 30:58–62. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li M, Sun H, Liu S, et al: CD40 C/T-1
polymorphism plays different roles in Graves' disease and
Hashimoto's thyroiditis: A meta-analysis. Endocr J. 59:1041–1050.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zeng H, Yan H, Zhang Z, Fang W, Ding R,
Huang L, Chen M and Zhang J: Association between IL-21 gene
rs907715 polymorphisms and Graves' disease in a Southern Chinese
population. Exp Ther Med. 8:213–218. 2014.PubMed/NCBI
|
|
16
|
Brunet JF, Denizot F, Luciani MF,
RouxDosseto M, Suzan M, Mattei MG and Golstein P: A new member of
the immunoglobulin superfamily - CTLA-4. Nature. 328:267–270. 1987.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yanagawa T, Hidaka Y, Guimaraes V, Soliman
M and DeGroot LJ: CTLA-4 gene polymorphism associated with Graves'
disease in a Caucasian population. J Clin Endocrinol Metab.
80:41–45. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Frydecka I, Daroszewski J, Suwalska K,
Zołedziowska M, Tutak A, Słowik M, Potoczek S and Dobosz T: CTLA-4
(CD152) gene polymorphism at position 49 in exon 1 in Graves'
disease in a Polish population of the Lower Silesian region. Arch
Immunol Ther Exp (Warsz). 52:369–374. 2004.PubMed/NCBI
|
|
19
|
Mochizuki M, Amemiya S, Kobayashi K,
Kobayashi K, Shimura Y, Ishihara T, Nakagomi Y, Onigata K, Tamai S,
Kasuga A, et al: Association of the CTLA-4 gene 49 A/G polymorphism
with type 1 diabetes and autoimmune thyroid disease in Japanese
children. Diabetes Care. 26:843–847. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Han SZ, Zhang SH, Li R, Zhang WY and Li Y:
The common −318C/T polymorphism in the promoter region of CTLA4
gene is associated with reduced risk of ophthalmopathy in Chinese
Graves' patients. Int J Immunogenet. 33:281–287. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang Q, Yang YM and Lv XY: Association of
Graves' disease and Graves' ophthalmopathy with the polymorphisms
in promoter and exon 1 of cytotoxic T lymphocyte associated
antigen-4 gene. J Zhejiang Univ Sci B. 7:887–891. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ban Y and Tomer Y: Susceptibility genes in
thyroid autoimmunity. Clin Dev Immunol. 12:47–58. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Furugaki K, Shirasawa S, Ishikawa N, Ito
K, Ito K, Kubota S, Kuma K, Tamai H, Akamizu T, Hiratani H, et al:
Association of the T-cell regulatory gene CTLA4 with Graves'
disease and autoimmune thyroid disease in the Japanese. J Hum
Genet. 49:166–168. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Benmansour J, Stayoussef M, AlJenaidi FA,
Rajab MH, Rayana CB, Said HB, Mahjoub T and Almawi WY: Association
of single nucleotide polymorphisms in cytotoxic T-lymphocyte
antigen 4 and susceptibility to autoimmune type 1 diabetes in
Tunisians. Clin Vaccine Immunol. 17:1473–1477. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ueda H, Howson JM, Esposito L, Heward J,
Snook H, Chamberlain G, Rainbow DB, Hunter KM, Smith AN, Di Genova
G, et al: Association of the T-cell regulatory gene CTLA4 with
susceptibility to autoimmune disease. Nature. 423:506–511. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Petrone A, Giorgi G, Galgani A, Alemanno
I, Corsello SM, Signore A, Di Mario U, Nisticò L, Cascino I and
Buzzetti R: CT60 single nucleotide polymorphisms of the cytotoxic
T-lymphocyte-associated antigen-4 gene region is associated with
Graves' disease in an Italian population. Thyroid. 15:232–238.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Daroszewski J, Pawlak E, Karabon L,
Frydecka I, Jonkisz A, Slowik M and Bolanowski M: Soluble CTLA-4
receptor an immunological marker of Graves' disease and severity of
ophthalmopathy is associated with CTLA-4 Jo31 and CT60 gene
polymorphisms. Eur J Endocrinol. 161:787–793. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Weng YC, Wu MJ and Lin WS: CT60 single
nucleotide polymorphism of the CTLA-4 gene is associated with
susceptibility to Graves' disease in the Taiwanese population. Ann
Clin Lab Sci. 35:259–264. 2005.PubMed/NCBI
|
|
29
|
Song HD, Liang J, Shi JY, et al:
Functional SNPs in the SCGB3A2 promoter are associated with
susceptibility to Graves' disease. Hum Mol Genet. 18:1156–1170.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Teft WA, Kirchhof MG and Madrenas J: A
molecular perspective of CTLA-4 function. Annu Rev Immunol.
24:65–97. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kimkong I, Nakkuntod J, SaeNgow S,
Snabboon T, Avihingsanon Y and Hirankarn N: Association between
CTLA-4 polymorphisms and the susceptibility to systemic lupus
erythematosus and Graves' disease in Thai population. Asian Pac J
Allergy Immunol. 29:229–235. 2011.PubMed/NCBI
|
|
32
|
Takahashi M and Kimura A: HLA and CTLA4
polymorphisms may confer a synergistic risk in the susceptibility
to Graves' disease. J Hum Genet. 55:323–326. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hunt KA, McGovern DP, Kumar PJ, et al: A
common CTLA4 haplotype associated with coeliac disease. Eur J Hum
Genet. 13:440–444. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Torres B, Aguilar F, Franco E, Sánchez E,
Sánchez-Román J, Jiménez Alonso J, Núñez-Roldán A, Martín J and
González-Escribano MF: Association of the CT60 marker of the CTLA4
gene with systemic lupus erythematosus. Arthritis Rheum.
50:2211–2215. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lei C, Dongqing Z, Yeqing S, Oaks MK,
Lishan C, Jianzhong J, Jie Q, Fang D, Ningli L, Xinghai H, et al:
Association of the CTLA-4 gene with rheumatoid arthritis in Chinese
Han population. Eur J Hum Genet. 13:823–828. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chang MC, Chang YT, Tien YW, Liang PC, Jan
IS, Wei SC and Wong JM: T-cell regulatory gene CTLA-4
polymorphism/haplotype association with autoimmune pancreatitis.
Clin Chem. 53:1700–1705. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Blomhoff A, Lie BA, Myhre AG, Kemp EH,
Weetman AP, Akselsen HE, Huseby ES and Undlien DE: Polymorphisms in
the cytotoxic T lymphocyte antigen-4 gene region confer
susceptibility to Addison's disease. J Clin Endocrinol Metab.
89:3474–3476. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ban Y, Tozaki T, Taniyama M, Tomita M and
Ban Y: Association of a CTLA-4 3′ untranslated region (CT60) single
nucleotide polymorphism with autoimmune thyroid disease in the
Japanese population. Autoimmunity. 38:151–153. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
PastuszakLewandoska D, Sewerynek E,
Domańska D, Gładyś A, Skrzypczak R and Brzeziańska E: CTLA-4 gene
polymorphisms and their influence on predisposition to autoimmune
thyroid diseases (Graves' disease and Hashimoto's thyroiditis).
Arch Med Sci. 8:415–421. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Mayans S, Lackovic K, Nyholm C, Lindgren
P, Ruikka K, Eliasson M, Cilio CM and Holmberg D: CT60 genotype
does not affect CTLA-4 isoform expression despite association to
T1D and AITD in northern Sweden. BMC Med Genet. 8:32007. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zhernakova A, Eerligh P, Barrera P, et al:
CTLA4 is differentially associated with autoimmune diseases in the
Dutch population. Hum Genet. 118:58–66. 2005. View Article : Google Scholar : PubMed/NCBI
|
